| Mrs Nicole Ann Porter, OTR/L | |
|
122 Leonardwood Dr, Frankfort, KY 40601-4278 | |
| (502) 871-4004 | |
| Not Available |
| Full Name | Mrs Nicole Ann Porter |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 6 Years |
| Location | 122 Leonardwood Dr, Frankfort, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760076954 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 263659 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Empowerme Rehabilitation Kentucky, Llc | 1850729211 | 87 |
News Archive
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
A new BC-based study aimed at understanding the genetic basis of lung cancer in people who have never smoked is being funded for approximately $379,000 by the Canadian Cancer Society.
A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc. has demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique that works by bouncing near-infrared laser light off biological tissue, can reliably distinguish between pancreatic cysts that are low-risk and high-risk for becoming malignant.
› Verified 8 days ago
| Provider Name | Empowerme Rehabilitation Kentucky, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275166696 PECOS PAC ID: 1850729211 Enrollment ID: O20200402002590 |
News Archive
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
A new BC-based study aimed at understanding the genetic basis of lung cancer in people who have never smoked is being funded for approximately $379,000 by the Canadian Cancer Society.
A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc. has demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique that works by bouncing near-infrared laser light off biological tissue, can reliably distinguish between pancreatic cysts that are low-risk and high-risk for becoming malignant.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Nicole Ann Porter, OTR/L 122 Leonardwood Dr, Frankfort, KY 40601-4278 Ph: (502) 871-4004 | Mrs Nicole Ann Porter, OTR/L 122 Leonardwood Dr, Frankfort, KY 40601-4278 Ph: (502) 871-4004 |
News Archive
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
Boehringer Ingelheim today announced the initiation of two phase II studies, 1200.89 and LUX-Breast 2, evaluating afatinib in patients with metastatic breast cancer, who have an overexpression of the erbB2 (HER2) protein, so called HER2-positive patients. Afatinib is an irreversible ErbB Family Blocker, which binds to all erbB-family kinases including erbB2.
A new BC-based study aimed at understanding the genetic basis of lung cancer in people who have never smoked is being funded for approximately $379,000 by the Canadian Cancer Society.
A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc. has demonstrated for the first time that optical coherence tomography (OCT), a high resolution optical imaging technique that works by bouncing near-infrared laser light off biological tissue, can reliably distinguish between pancreatic cysts that are low-risk and high-risk for becoming malignant.
› Verified 8 days ago
Christie Courrejoles, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 299 Kings Daughters Dr, Frankfort, KY 40601 Phone: 502-226-1405 | |
Ashley Mae Byers, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 Democrat Dr, Frankfort, KY 40601 Phone: 502-352-2330 | |
Cheryl Lea Harrod, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 102 Leonardwood Dr, Frankfort, KY 40601 Phone: 502-783-1556 | |
Mrs. Mary Julia Smarr, OTL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: First Steps Program Department For Public, 275 E. Main St. Hs2w-c, Frankfort, KY 40621 Phone: 877-417-8370 | |
Rebecca Allison, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1780 Union Ridge Rd, Frankfort, KY 40601 Phone: 502-535-5917 | |
Mr. Mark Joseph Russell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 275 East Main Street, Frankfort, KY 40621 Phone: 502-564-3756 | |
Natalie Bault, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 122 Leonardwood Dr, Frankfort, KY 40601 Phone: 502-385-0736 |